Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response
NCT ID: NCT03430414
Last Updated: 2018-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2018-02-15
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies
NCT05306795
Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
NCT07134491
Urine Biomarker for Kidney Transplant Rejection
NCT05072951
Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation
NCT03098238
Cell-based Assays for Antibody-mediated Transplant Rejection
NCT03916822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapy Responders
Transcriptome Analysis
Transcriptome Analysis of Formalin Fixed Paraffin Embedded biopsies
Non-Responders
Transcriptome Analysis
Transcriptome Analysis of Formalin Fixed Paraffin Embedded biopsies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcriptome Analysis
Transcriptome Analysis of Formalin Fixed Paraffin Embedded biopsies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written consent for further use of data for research purposes
Exclusion Criteria
* Combined organ transplantation (incl. Kidney-Pancreas, Kidney-Liver, Kidney-Heart)
* Incomplete laboratory and/or clinical data
* Recurrence of the initial disease
* Insufficient Biopsy Material for NanoString Analysis
* Documented refusal of further data analysis for research purpose
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thomas Mueller
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Mueller
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Sazpinar O, Gaspert A, Sidler D, Rechsteiner M, Mueller TF. Histologic and Molecular Patterns in Responders and Non-responders With Chronic-Active Antibody-Mediated Rejection in Kidney Transplants. Front Med (Lausanne). 2022 Apr 29;9:820085. doi: 10.3389/fmed.2022.820085. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BASEC-Nr. 2017-02130
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.